首页> 外文期刊>Oncolytic Virotherapy >Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells
【24h】

Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells

机译:口服脊髓灰质炎病毒疫苗诱导的程序性细胞死亡涉及人类结直肠癌细胞的内在和外在途径

获取原文
       

摘要

Purpose: Colorectal cancer (CRC) is one of the most common causes of cancer death throughout the world. Replication-competent viruses, which are naturally able to infect and lyse tumor cells, seem to be promising in this field. The aim of this study was to evaluate the potential of oral poliovirus vaccine (OPV) on human CRC cells and elucidate the mechanism of apoptosis induction. Materials and methods: Protein and gene expression of poliovirus (PV) receptor (CD155) on four human CRC cell lines including HCT116, SW480, HT-29, and Caco-2 and normal fetal human colon (FHC) cell line as a control were examined by flow cytometry and SYBR Green Real-Time PCR, respectively. Cytotoxicity of OPV on indicated cell lines was tested using MTT assay. The ability of OPV on apoptosis induction for both intrinsic and extrinsic pathways was examined using caspase-8 and caspase-9 colorimetric assay kits. The PV propagation in mentioned cell lines was investigated, and the quantity of viral yields (cells associated and extracellular) was determined using TaqMan PCR. Results: CD155 mRNA and protein were expressed significantly higher in studied CRC cell lines rather than the normal cell line ( P =0). OPV induced cell death in a time- and dose-dependent manner in human CRC cells. Apoptosis through both extrinsic and intrinsic pathways was detected in CRC cells with the minimum level found in FHC. PV viral load was significantly correlated with apoptosis via extrinsic ( R =0.945, P =0.0001) and intrinsic ( R =0.756, P =0.001) pathways. Conclusion: This study suggests that OPV has potential for clinical treatment of CRC. However further studies in animal models (tumor xenografts) are needed to be certain that it is qualified enough for treatment of CRC.
机译:目的:大肠癌(CRC)是全世界癌症死亡的最常见原因之一。具有复制能力的病毒,自然能够感染和裂解肿瘤细胞,在该领域似乎很有希望。这项研究的目的是评估口服脊髓灰质炎病毒疫苗(OPV)对人CRC细胞的潜力,并阐明凋亡诱导机制。材料和方法:脊髓灰质炎病毒(PV)受体(CD155)在包括HCT116,SW480,HT-29和Caco-2在内的四种人CRC细胞系和正常胎儿结肠(FHC)细胞系上的蛋白质和基因表达分别通过流式细胞仪和SYBR Green Real-Time PCR检测。使用MTT测定法测试了OPV对指定细胞系的细胞毒性。使用caspase-8和caspase-9比色分析试剂盒检查了OPV诱导内源性和外源性途径凋亡的能力。研究了在上述细胞系中的PV传播,并使用TaqMan PCR确定了病毒产量(相关细胞和细胞外)的数量。结果:在研究的CRC细胞系中CD155 mRNA和蛋白的表达明显高于正常细胞系(P = 0)。 OPV在人CRC细胞中以时间和剂量依赖性方式诱导细胞死亡。在FHC中发现的最低水平通过CRC细胞检测到通过外在和内在途径的凋亡。 PV病毒载量与通过外源性途径(R = 0.945,P = 0.0001)和内在性途径(R = 0.756,P = 0.001)的凋亡均显着相关。结论:这项研究表明,OPV在CRC的临床治疗中具有潜力。但是,需要在动物模型(肿瘤异种移植物)中进行进一步研究,以确保其足以治疗CRC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号